The Japanese Data Center for Hematopoietic Cell Transplantation

Recent papers from The Japanese Data Center for Hematopoietic Cell Transplantation

1. Invasive fusariosis after allogeneic hematopoietic cell transplantation: clinical features and prognostic value of serum β-D-glucan in a nationwide Japanese registry studyMedical Mycology · 2026
2. Second allogeneic haematopoietic stem cell transplantation for non‐malignant diseasesBritish Journal of Haematology · 2026
3. Adverse impact of deletion of the chromosome 6 on clinical outcomes after allogeneic hematopoietic transplantationBlood Advances · 2026
4. Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysisHaematologica · 2026
5. Optimizing cord blood unit selection to improve survival after single‐unit unrelated cord blood transplantation for adult myelodysplastic syndromeBritish Journal of Haematology · 2026
6. Comparison of post‐transplant cyclophosphamide and low‐dose anti‐thymocyte globulin with dose‐dependent effects in mismatched unrelated donor transplantationBritish Journal of Haematology · 2026
7. Novel targeted therapy and cellular immunotherapy enabling allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute myeloid leukemiaChinese Medical Journal · 2026
8. Prognostic factors of 10-year survival in patients with myeloma after autologous stem cell transplantation: a multicenter retrospective analysisLeukemia & lymphoma/Leukemia and lymphoma · 2026
9. Development of a stacked ensemble model for risk stratification of chronic GVHD after allogeneic HSCT: Japanese nation-wide cohort studyFrontiers in Immunology · 2026
10. ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CMLBlood Advances · 2026
11. Novel KIR2DS4:HLA-B*35 interaction predicts HLA-B*35 positive patient survival post hematopoietic stem cell transplant2026
12. Body Composition, Nutritional Status, and Dietary Intake in the First 100 Days After Stem Cell Transplantation and Their Link to One-Year Mortality in Leukemia PatientsNutrition and Cancer · 2026
13. Letermovir coadministration and tacrolimus concentration-to-dose ratios before and after intravenous-to-oral conversion in allogeneic hematopoietic stem cell transplant recipients receiving isavuconazoleJapanese Journal of Clinical Oncology · 2026
14. Body mass index and outcomes after CD19 CAR T-cell therapy for relapsed/refractory B-cell lymphoma: a nationwide registry studyBiology of Blood and Marrow Transplantation · 2026
15. Donor age as a dual‐risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantationBritish Journal of Haematology · 2026
16. Repurposing mitochondrial-targeting drugs for management of ICANS in CAR T-cell therapy: a novel steroid-sparing approachFrontiers in Pharmacology · 2026
17. Conditioning-adapted methotrexate in cord blood transplantation for high-risk acute myeloid leukemia: a nationwide Japanese cohort analysisScientific Reports · 2026
18. Infants show improving survival after hematopoietic cell transplantation despite high rates of critical care admissionFrontiers in Anesthesiology · 2026
19. Application Timing‐Dependent Impact of Donor Source on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation for Adult T‐Cell Leukemia/LymphomaHematological Oncology · 2026
20. Case Report: Fibrosis appearing as disease progression on PET/CT following R-CHOP in newly diagnosed DLBCLFrontiers in Oncology · 2026